期刊文献+

多囊卵巢综合征所致不孕者不同卵泡期HMG促排卵方案的效果随访分析 被引量:20

Follow-up analysis of the effect of HMG ovulation induction program in different follicular stages of infertility caused by polycystic ovary syndrome
下载PDF
导出
摘要 为研究在卵泡中期加入促性腺激素(HMG)的促排卵作用,选取在本院生殖科门诊就诊的106例多囊卵巢综合征所致的不孕患者,比较观察早卵泡期组和中卵泡期组促排卵方案的治疗效果及妊娠结局。结果表明,与中卵泡期组比较,早卵泡期组的成熟卵泡数较多,人绒毛膜促性腺激素(HCG)日子宫膜厚度较厚,HMG用量少,妊娠率高。结果表明,在卵泡早期加入HMG的促排卵方案优于在卵泡中期加入HMG的促排卵方案,有助于提高妊娠率。 To study the ovulation induction regimen of adding HMG in the mid-follicles,106 cases of infertility caused by polycystic ovary syndrome in reproductive clinic of our hospital were selected.The therapeutic effects and pregnancy outcomes of the early follicular phase group and middle follicular phase group were observed and compared.The results showed,compared to the middle follicular phase group,that the number of mature follicles in the early follicular phase group was higher,the thickness of the uterine membrane of HCG was thicker,and the amount of HMG was lower,the pregnancy rate was higher.The results indicated that ovulation induction regimen of adding HMG in the early stage of follicles is superior to the ovulation induction regimen of adding HMG in the mid-follicles,which helps to improve the pregnancy rate.
作者 刘霞 王琳 LIU Xia;WANG Lin(Department of Obstetrics and Gynecology,Taizhou People s Hospital,Taizhou 225300,Jiangsu,China)
出处 《中南医学科学杂志》 CAS 2020年第1期32-34,共3页 Medical Science Journal of Central South China
关键词 多囊卵巢综合征 卵泡期 促尿性素 polycystic ovary syndrome follicular phase urinary tract
  • 相关文献

参考文献4

二级参考文献22

  • 1Glenn Paul Dorsam,Keith Benton,Jarrett Failing,Sandeep Batra.Vasoactive intestinal peptide signaling axis in human leukemia[J].World Journal of Biological Chemistry,2011,2(6):146-160. 被引量:4
  • 2Zhao Y, Du B, Jiang X, et al. Effects of combining low- dose aspirin with a Chinese patent medicine on follicular blood flow and pregnancy outcome [ J ]. Mol Med Rep, 2014,10 (5) :2372- 2376.
  • 3Fauser B C, Tarlatzis B C, Rebar R W, et al. Consensus on women's health aspects of polycystic ovary syndrome ( P- COS): the Amsterdam ESHRE/ASRM-Sponsored 3rd P- COS Consensus Workshop Group[J]. Fertil Steril. , 2012, 97( 1 ) :28-38.
  • 4The Rotterdam ESHER/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus of diagnostic cri- teria and long-term health risks related to polycystic ovary syndrome(PCOS). Hum Reprod, 2004,19( 1 ) :41-47.
  • 5Salameh W A, Redor-Goldman M M, Clarke N J, et al. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria [ J ]. Fertil Steril, 2014, 101 ( 4 ) : 1135-1141.
  • 6Wang T, Guo Y, Song and W Huang. ' Association dipocyte factor level and insulin resistance in polycystic ovary syn- drome' [ J ]. Gynecological Endocrinology, 2011,27 ( 11 ) : p931- p934.
  • 7Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystie ovary syndrome [ J ]. Fertil Steril, 2008,89 (3) :505-522.
  • 8Dewailly D, Catteau-Jonard S, Reyss AC, et al. Oligo- anovulation with polyeystic ovaries but not overt hyperandro- genism[ J ]. J Clin Endocrinol Metab, 2006,91 (10) : 3922-3927.
  • 9Welt C K, Gudmundsson J A, Arsson G, et al. Characteri- zin discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on pheno- type and metabolic feature [ J]. J Clin Endocrinol Metab, 2006, 91:4842-4848.
  • 10Guastella E, Longo R A, Carmina E. Clinical and endo- crine characteristics of the main polycystic ovary syndrome phenotypes[ J ]. Fertil and Steril, 2010, 94 ( 6 ) : 2197 - 2201.

共引文献79

同被引文献209

引证文献20

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部